The diagnosis and treatment of osteoporosis: future prospects

被引:27
作者
Baylink, DJ [1 ]
Strong, DD
Mohan, S
机构
[1] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA
[2] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr 151, Loma Linda, CA 92357 USA
[3] Loma Linda Univ, Dept Microbiol, Loma Linda, CA 92354 USA
[4] Loma Linda Univ, Dept Mol Genet & Biochem, Loma Linda, CA 92354 USA
来源
MOLECULAR MEDICINE TODAY | 1999年 / 5卷 / 03期
关键词
D O I
10.1016/S1357-4310(98)01426-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoporosis is a common disease that affects millions of patients throughout the world. We anticipate that both the diagnosis and the treatment of this disease will be revolutionized by the integration of genomics and informatics. It is predicted that a genetic algorithm will be developed to identify at-risk patients before they develop osteoporosis, so that preventive measures can be instituted. The sequencing of the human genome will lead to revolutionary advances in at least three areas of osteoporosis therapy: small molecule therapy, protein therapy and gene therapy. One area of focus for future therapeutics in osteoporosis will be on osteogenic agents, which should have a high likelihood of success because the skeleton has the innate capacity to regenerate itself.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 58 条
  • [1] Adams S, 1998, INT CONGR SER, V1151, P327
  • [2] Rationale for active vitamin D analog therapy in senile osteoporosis
    Akesson, K
    Lau, KHW
    Baylink, DJ
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (01) : 100 - 105
  • [3] Anderson WF, 1998, NATURE, V392, P25
  • [4] Baylink DJ, 1999, PRINCIPLES GERIATRIC, P1041
  • [5] Genetic variability in adult bone density among inbred strains of mice
    Beamer, WG
    Donahue, LR
    Rosen, CJ
    Baylink, DJ
    [J]. BONE, 1996, 18 (05) : 397 - 403
  • [6] BEAMER WG, 1998, BONE, V23, pS162
  • [7] PREDICTION OF THE COMPRESSIVE STRENGTH OF HUMAN LUMBAR VERTEBRAE
    BRINCKMANN, P
    BIGGEMANN, M
    HILWEG, D
    [J]. SPINE, 1989, 14 (06) : 606 - 610
  • [8] Monoclonal antibodies reactive with human osteogenic cell surface antigens
    Bruder, SP
    Horowitz, MC
    Mosca, JD
    Haynesworth, SE
    [J]. BONE, 1997, 21 (03) : 225 - 235
  • [9] Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence
    Cosman, F
    Lindsay, R
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (06) : 475 - 480
  • [10] Crooke ST, 1998, NAT BIOTECHNOL, V16, P1319